🔗 Share this article

This year's Nobel Prize in Physiology or Medicine has been awarded for transformative findings that clarify how the immune system targets dangerous infections while protecting the healthy tissues.

Three renowned scientists—Japan's Prof. Sakaguchi and American scientists Mary Brunkow and Fred Ramsdell—received this accolade.

Their work identified unique "sentinels" within the defense system that remove malfunctioning defense cells that could harming the organism.

The discoveries are now paving the way for innovative treatments for immune disorders and malignancies.

The winners will share a monetary award valued at 11 million Swedish kronor.

Decisive Findings

"Their work has been decisive for comprehending how the immune system functions and why we do not all develop serious autoimmune diseases," commented the head of the award panel.

The trio's research address a core question: In what way does the immune system defend us from numerous invaders while keeping our healthy cells intact?

Our immune system uses immune cells that scan for indicators of disease, even pathogens and bacteria it has not met before.

Such cells employ sensors—known as receptors—that are produced randomly in a vast number of combinations.

That gives the immune system the ability to fight a broad range of threats, but the unpredictability of the process unavoidably creates immune cells that can target the host.

Security Guards of the Body

Scientists previously understood that some of these harmful defense cells were eliminated in the immune organ—where white blood cells mature.

This year's award honors the identification of T-reg cells—known as the immune system's "security guards"—which patrol the system to disarm any defenders that assault the body's own tissues.

We know that this mechanism malfunctions in self-attack conditions such as juvenile diabetes, MS, and rheumatoid arthritis.

The prize committee stated, "The findings have established a novel area of research and spurred the creation of innovative therapies, for instance for cancer and immune disorders."

In malignancies, T-regs block the body from attacking the tumor, so research are focused on reducing their quantity.

In autoimmune diseases, trials are exploring boosting T-reg cells so the organism is no longer under attack. A similar method could also be effective in reducing the risks of organ transplant rejection.

Innovative Studies

Prof Shimon Sakaguchi, of a Japanese institution, conducted tests on mice that had their immune gland extracted, leading to autoimmune disease.

The researcher demonstrated that introducing immune cells from healthy mice could prevent the illness—implying there was a mechanism for preventing defenders from attacking the host.

Dr. Brunkow, affiliated with the Institute for Systems Biology in Seattle, and Fred Ramsdell, now at Sonoma Biotherapeutics in a California city, were studying an genetic immune disorder in rodents and people that resulted in the identification of a gene critical for the way T-regs function.

"Their groundbreaking research has revealed how the immune system is controlled by regulatory T cells, preventing it from accidentally targeting the healthy cells," commented a prominent biological science specialist.

"This work is a striking illustration of how basic physiological study can have far-reaching consequences for human health."